Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

ClinicalTrials.gov ID: NCT02879305

Public ClinicalTrials.gov record NCT02879305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents

Study identification

NCT ID
NCT02879305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
2,964 participants

Conditions and interventions

Interventions

  • Daprodustat Drug
  • rhEPO Drug
  • Placebo Drug
  • Iron therapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2016
Primary completion
Nov 8, 2020
Completion
Nov 8, 2020
Last update posted
Dec 2, 2021

2016 – 2020

United States locations

U.S. sites
126
U.S. states
32
U.S. cities
106
Facility City State ZIP Site status
GSK Investigational Site Huntsville Alabama 35805
GSK Investigational Site Pine Bluff Arkansas 71603
GSK Investigational Site Anaheim California 92801
GSK Investigational Site Bakersfield California 93308
GSK Investigational Site Bakersfield California 93309
GSK Investigational Site Beverly Hills California 90211
GSK Investigational Site Cerritos California 90703
GSK Investigational Site Chula Vista California 91910
GSK Investigational Site El Centro California 92243
GSK Investigational Site Escondido California 92025
GSK Investigational Site Fairfield California 94534
GSK Investigational Site Fountain Valley California 92708
GSK Investigational Site Glendale California 91205
GSK Investigational Site Granada Hills California 91344
GSK Investigational Site Hacienda Heights California 91745
GSK Investigational Site La Mesa California 91942
GSK Investigational Site La Palma California 90623
GSK Investigational Site Lakewood California 90712
GSK Investigational Site Long Beach California 90806
GSK Investigational Site Long Beach California 90807
GSK Investigational Site Long Beach California 90813
GSK Investigational Site Los Angeles California 90022
GSK Investigational Site Los Angeles California 90095
GSK Investigational Site Lynwood California 60262
GSK Investigational Site Montebello California 90640
GSK Investigational Site Monterey Park California 91754
GSK Investigational Site Moreno Valley California 92553
GSK Investigational Site Norco California 92860
GSK Investigational Site Northridge California 91324
GSK Investigational Site Ontario California 91762
GSK Investigational Site Riverside California 92501
GSK Investigational Site Sacramento California 95825
GSK Investigational Site San Diego California 92103
GSK Investigational Site San Diego California 92111
GSK Investigational Site San Luis Obispo California 93405
GSK Investigational Site Santa Clarita California 91387
GSK Investigational Site Simi Valley California 93065-091
GSK Investigational Site Tarzana California 91356
GSK Investigational Site Whittier California 90602
GSK Investigational Site Whittier California 90603
GSK Investigational Site Yorba Linda California 92886
GSK Investigational Site Middlebury Connecticut 06762
GSK Investigational Site Washington D.C. District of Columbia 20037
GSK Investigational Site Aventura Florida 33180
GSK Investigational Site Coral Gables Florida 33134
GSK Investigational Site Hollywood Florida 33024
GSK Investigational Site Jacksonville Florida 32224
GSK Investigational Site Lauderdale Lakes Florida 33313
GSK Investigational Site Miami Florida 33126
GSK Investigational Site Miami Florida 33143
GSK Investigational Site Miami Florida 33150
GSK Investigational Site Miami Florida 33156
GSK Investigational Site Miami Gardens Florida 33169
GSK Investigational Site Ocala Florida 34471
GSK Investigational Site Port Charlotte Florida 33952
GSK Investigational Site Spring Hill Florida 34608
GSK Investigational Site Winter Park Florida 32789
GSK Investigational Site Augusta Georgia 30904
GSK Investigational Site Augusta Georgia 30912
GSK Investigational Site Columbus Georgia 31904
GSK Investigational Site Meridian Idaho 83642
GSK Investigational Site Crystal Lake Illinois 60014
GSK Investigational Site Fort Wayne Indiana 46804
GSK Investigational Site Jeffersonville Indiana 47130
GSK Investigational Site Merrillville Indiana 46410
GSK Investigational Site Michigan City Indiana 46360
GSK Investigational Site Iowa City Iowa 52242
GSK Investigational Site Louisville Kentucky 40202
GSK Investigational Site Baton Rouge Louisiana 70808
GSK Investigational Site Baton Rouge Louisiana 70836
GSK Investigational Site Greenbelt Maryland 20770
GSK Investigational Site Takoma Park Maryland 20912-6385
GSK Investigational Site Kalamazoo Michigan 49007
GSK Investigational Site Pontiac Michigan 48341
GSK Investigational Site Roseville Michigan 48066
GSK Investigational Site Gulfport Mississippi 39501
GSK Investigational Site Tupelo Mississippi 38801
GSK Investigational Site Florissant Missouri 63033
GSK Investigational Site Kansas City Missouri 64111
GSK Investigational Site St Louis Missouri 63110
GSK Investigational Site Las Vegas Nevada 89102
GSK Investigational Site Las Vegas Nevada 89107
GSK Investigational Site Portsmouth New Hampshire 3801
GSK Investigational Site Gallup New Mexico 87301
GSK Investigational Site Brooklyn New York 11203
GSK Investigational Site Buffalo New York 14215
GSK Investigational Site Flushing New York 11355
GSK Investigational Site Mineola New York 11501
GSK Investigational Site New York New York 10029
GSK Investigational Site Ridgewood New York 11385
GSK Investigational Site The Bronx New York 10461
GSK Investigational Site Yonkers New York 10710
GSK Investigational Site Asheville North Carolina 28801
GSK Investigational Site Clyde North Carolina 28721
GSK Investigational Site Raleigh North Carolina 27609
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Winston-Salem North Carolina 27517
GSK Investigational Site Canton Ohio 44718
GSK Investigational Site Cincinnati Ohio 45206
GSK Investigational Site Cincinnati Ohio 45220
GSK Investigational Site Roseburg Oregon 97471
GSK Investigational Site Bethlehem Pennsylvania 18017
GSK Investigational Site Philadelphia Pennsylvania 19140
GSK Investigational Site Providence Rhode Island 02903
GSK Investigational Site Anderson South Carolina 29621
GSK Investigational Site Charleston South Carolina 29425
GSK Investigational Site Sumter South Carolina 29150
GSK Investigational Site Cordova Tennessee 38018
GSK Investigational Site Knoxville Tennessee 37923
GSK Investigational Site Knoxville Tennessee 37924
GSK Investigational Site Nashville Tennessee 37205
GSK Investigational Site Beaumont Texas 77701
GSK Investigational Site Houston Texas 77004
GSK Investigational Site Houston Texas 77030
GSK Investigational Site Houston Texas 77099
GSK Investigational Site Lufkin Texas 75904
GSK Investigational Site San Antonio Texas 78207
GSK Investigational Site San Antonio Texas 78221
GSK Investigational Site San Antonio Texas 78251
GSK Investigational Site San Antonio Texas 78258
GSK Investigational Site Alexandria Virginia 22304
GSK Investigational Site Fairfax Virginia 22033
GSK Investigational Site Hampton Virginia 23666
GSK Investigational Site Salem Virginia 24153
GSK Investigational Site Bluefield West Virginia 24701
GSK Investigational Site Shorewood Wisconsin 53211

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 336 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02879305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02879305 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →